Ipamorelin was on the FDA's Category 2 503A compounding list from September 2023 to September 2024, then removed after the nominator withdrew
Search strategy and study selection We conducted a comprehensive search through PubMed, Scopus, and Web of Science databases to identify pertinent studies from their inception until March 2024
Prokinetic agents like metoclopramide present a theoretical option but should be used cautiously given potential adverse effects (including tardive dyskinesia with use beyond 12 weeks) and the counterintuitive nature of accelerating gastric emptying while using a medication that intentionally slows it
While the specific hour does not impact the medications effectiveness, many people choose a time based on managing potential side effects, such as taking it in the evening to sleep through initial nausea
Maternal folate nutrition and offspring health: Evidence and current controversies
Initially, the reduced expression of AKT3 identified in this study following the treatment of cancer cells with pDNA/Polybia-MP1 is a noteworthy discovery, diverging from its usual oncogenic and anti-apoptotic functions